{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:44:01Z","timestamp":1792579441794,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-03050-8","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:22:34Z","timestamp":1792578154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and management of polycystic ovary syndrome\/polyendocrine metabolic ovarian syndrome: unmet needs and areas of clinical confidence among European endocrinologists"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-1521","authenticated-orcid":false,"given":"Sarantis","family":"Livadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-7662","authenticated-orcid":false,"given":"Bulent O.","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-1807","authenticated-orcid":false,"given":"Barbara","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6734","authenticated-orcid":false,"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-7004","authenticated-orcid":false,"given":"Duarte","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-3984","authenticated-orcid":false,"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2601-2694","authenticated-orcid":false,"given":"Flaminia","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6890-1644","authenticated-orcid":false,"given":"H\u00e9ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1929-3275","authenticated-orcid":false,"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-9504","authenticated-orcid":false,"given":"Marianne Skovsager","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-2678","authenticated-orcid":false,"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-6069","authenticated-orcid":false,"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-8596","authenticated-orcid":false,"given":"Djuro","family":"Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"3050_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","volume":"310","author":"N Salari","year":"2024","unstructured":"Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S et al (2024) Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet 310:1303\u20131314. https:\/\/doi.org\/10.1007\/s00404-024-07607-x","journal-title":"Arch Gynecol Obstet"},{"key":"3050_CR2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31:2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"key":"3050_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/cen.14193","volume":"93","author":"U Ezeh","year":"2020","unstructured":"Ezeh U, Ida Chen Y-D, Azziz R (2020) Racial and ethnic differences in the metabolic response of polycystic ovary syndrome. Clin Endocrinol (Oxf) 93:163\u2013172. https:\/\/doi.org\/10.1111\/cen.14193","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3050_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/14647273.2011.632058","volume":"14","author":"D Sivayoganathan","year":"2011","unstructured":"Sivayoganathan D, Maruthini D, Glanville JM, Balen AH (2011) Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity. Hum Fertil (Camb) 14:261\u2013265. https:\/\/doi.org\/10.3109\/14647273.2011.632058","journal-title":"Hum Fertil (Camb)"},{"key":"3050_CR5","doi-asserted-by":"publisher","first-page":"e0226074","DOI":"10.1371\/journal.pone.0226074","volume":"14","author":"TT Piltonen","year":"2019","unstructured":"Piltonen TT, Ruokoj\u00e4rvi M, Karro H, Kujanp\u00e4\u00e4 L, Morin-Papunen L, Tapanainen JS et al (2019) Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe. PLoS ONE 14:e0226074. https:\/\/doi.org\/10.1371\/journal.pone.0226074","journal-title":"PLoS ONE"},{"key":"3050_CR6","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT et al (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol 189:G43\u2013G64. https:\/\/doi.org\/10.1093\/ejendo\/lvad096","journal-title":"Eur J Endocrinol"},{"key":"3050_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/ejendo\/lvae085","volume":"191","author":"S Livadas","year":"2024","unstructured":"Livadas S, Yildiz BO, Mastorakos G, Gambineri A, Pignatelli D, Giorgino F et al (2024) European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group\u2019s 2023 Questionnaire. Eur J Endocrinol 191:134\u2013143. https:\/\/doi.org\/10.1093\/ejendo\/lvae085","journal-title":"Eur J Endocrinol"},{"key":"3050_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/EJE-14-0252","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A et al (2014) European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group\u2019s Questionnaire. Eur J Endocrinol 171:489\u2013498. https:\/\/doi.org\/10.1530\/EJE-14-0252","journal-title":"Eur J Endocrinol"},{"key":"3050_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"3050_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456\u2013488. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035","journal-title":"Fertil Steril"},{"key":"3050_CR11","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"JK Zawadzki","year":"1992","unstructured":"Zawadzki JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds) Polycystic ovary syndrome. Blackwell Scientific, Boston, pp 377\u2013384"},{"key":"3050_CR12","unstructured":"Rebar RW (2024) Ovulatory dysfunction. MSD Manual Professional Edition. https:\/\/www.msdmanuals.com\/professional\/gynecology-and-obstetrics\/infertility-andrecurrent-pregnancy-loss\/ovulatory-dysfunction. Accessed 20 May 2024"},{"key":"3050_CR13","unstructured":"Diseases (2026) & Conditions. Oligomenorrhoea. Cleveland Clinic https:\/\/my.clevelandclinic.org\/health\/symptoms\/22834-oligomenorrhea. Accessed 30 July 2026"},{"key":"3050_CR14","unstructured":"Riaz Y, Parekh U (2024) Oligomenorrhea. In: StatPearls. StatPearls Publishing, Treasure Island. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560575\/. Accessed 20 May 2024"},{"key":"3050_CR15","unstructured":"Welt CK (2025) Patient education: absent or irregular periods (Beyond the Basics). UpToDate. https:\/\/www.uptodate.com\/contents\/absent-or-irregular-periods-beyondthe-basics. Accessed 30 July 2026"},{"key":"3050_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41746-023-00848-1","volume":"6","author":"H Li","year":"2023","unstructured":"Li H, Gibson EA, Jukic AMZ, Baird DD, Wilcox AJ, Curry CL et al (2023) Menstrual cycle length variation by demographic characteristics from the Apple Women\u2019s Health Study. NPJ Digit Med 6:100. https:\/\/doi.org\/10.1038\/s41746-023-00848-1","journal-title":"NPJ Digit Med"},{"key":"3050_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.steroids.2015.06.013","volume":"101","author":"R Leiva","year":"2015","unstructured":"Leiva R, Bouchard T, Boehringer H, Abulla S, Ecochard R (2015) Random serum progesterone threshold to confirm ovulation. Steroids 101:125\u2013129. https:\/\/doi.org\/10.1016\/j.steroids.2015.06.013","journal-title":"Steroids"},{"key":"3050_CR18","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1210\/jc.2015-4009","volume":"101","author":"R Pasquali","year":"2016","unstructured":"Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM et al (2016) Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. J Clin Endocrinol Metab 101:2013\u20132022. https:\/\/doi.org\/10.1210\/jc.2015-4009","journal-title":"J Clin Endocrinol Metab"},{"key":"3050_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1210\/jc.2016-2963","volume":"102","author":"M Gibson-Helm","year":"2017","unstructured":"Gibson-Helm M, Teede H, Dunaif A, Dokras A (2017) Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 102:604\u2013612. https:\/\/doi.org\/10.1210\/jc.2016-2963","journal-title":"J Clin Endocrinol Metab"},{"key":"3050_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/humupd\/dmp024","volume":"16","author":"BO Yildiz","year":"2010","unstructured":"Yildiz BO, Bolour S, Woods K, Moore A, Azziz R (2010) Visually scoring hirsutism. Hum Reprod Update 16:51\u201364. https:\/\/doi.org\/10.1093\/humupd\/dmp024","journal-title":"Hum Reprod Update"},{"key":"3050_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/medsci7070078","volume":"7","author":"B Keevil","year":"2019","unstructured":"Keevil B (2019) Steroid Mass Spectrometry for the Diagnosis of PCOS. Med Sci (Basel) 7:78. https:\/\/doi.org\/10.3390\/medsci7070078","journal-title":"Med Sci (Basel)"},{"key":"3050_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40618-024-02416-0","volume":"48","author":"M Luque-Ram\u00edrez","year":"2024","unstructured":"Luque-Ram\u00edrez M, Mart\u00ednez-Garc\u00eda M\u00c1, Insenser M, Fern\u00e1ndez-Dur\u00e1n E, Quintero-Tobar A, Fiers T et al (2024) Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting. J Endocrinol Invest 48:131\u2013143. https:\/\/doi.org\/10.1007\/s40618-024-02416-0","journal-title":"J Endocrinol Invest"},{"key":"3050_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1210\/jc.2016-3285","volume":"102","author":"MW O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly MW, Kempegowda P, Jenkinson C, Taylor AE, Quanson JL, Storbeck K-H et al (2017) 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102:840\u2013848. https:\/\/doi.org\/10.1210\/jc.2016-3285","journal-title":"J Clin Endocrinol Metab"},{"key":"3050_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405\u2013413. https:\/\/doi.org\/10.1210\/jc.2006-1864","journal-title":"J Clin Endocrinol Metab"},{"key":"3050_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","volume":"145","author":"MO Goodarzi","year":"2015","unstructured":"Goodarzi MO, Carmina E, Azziz R (2015) DHEA, DHEAS and PCOS. J Steroid Biochem Mol Biol 145:213\u2013225. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.06.003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3050_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","volume":"47","author":"S Livadas","year":"2014","unstructured":"Livadas S, Pappas C, Karachalios A, Marinakis E, Tolia N, Drakou M et al (2014) Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome. Endocrine 47:631\u2013638. https:\/\/doi.org\/10.1007\/s12020-014-0200-7","journal-title":"Endocrine"},{"key":"3050_CR27","doi-asserted-by":"publisher","first-page":"e23539","DOI":"10.1002\/jcla.23539","volume":"34","author":"Z Cao","year":"2020","unstructured":"Cao Z, Lu Y, Cong Y, Liu Y, Li Y, Wang H et al (2020) Simultaneous quantitation of four androgens and 17\u2013hydroxyprogesterone in polycystic ovarian syndrome patients by LC\u2013MS\/MS. J Clin Lab Anal 34:e23539. https:\/\/doi.org\/10.1002\/jcla.23539","journal-title":"J Clin Lab Anal"},{"key":"3050_CR28","doi-asserted-by":"publisher","first-page":"100598","DOI":"10.1016\/j.lanepe.2023.100598","volume":"28","author":"A Berglund","year":"2023","unstructured":"Berglund A, Ornstrup MJ, Lind-Holst M, Dun\u00f8 M, B\u00e6kvad-Hansen M, Juul A et al (2023) Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population-based study. Lancet Reg Health Eur 28:100598. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100598","journal-title":"Lancet Reg Health Eur"},{"key":"3050_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fendo.2019.00366","volume":"10","author":"S Livadas","year":"2019","unstructured":"Livadas S, Bothou C (2019) Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach. Front Endocrinol (Lausanne) 10:366. https:\/\/doi.org\/10.3389\/fendo.2019.00366","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3050_CR30","doi-asserted-by":"publisher","first-page":"1251866","DOI":"10.3389\/fendo.2023.1251866","volume":"14","author":"S Palomba","year":"2023","unstructured":"Palomba S, Colombo C, Busnelli A, Caserta D, Vitale G (2023) Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature. Front Endocrinol (Lausanne) 14:1251866. https:\/\/doi.org\/10.3389\/fendo.2023.1251866","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3050_CR31","doi-asserted-by":"publisher","first-page":"117955811987192","DOI":"10.1177\/1179558119871921","volume":"13","author":"C Delcour","year":"2019","unstructured":"Delcour C, Robin G, Young J, Dewailly D (2019) PCOS and Hyperprolactinemia: what do we know in 2019? Clin Med Insights Reprod Health 13:1179558119871921. https:\/\/doi.org\/10.1177\/1179558119871921","journal-title":"Clin Med Insights Reprod Health"},{"key":"3050_CR32","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1002\/ehf2.14104","volume":"9","author":"GMC Rosano","year":"2022","unstructured":"Rosano GMC, Rodriguez\u2013Martinez MA, Spoletini I, Regidor PA (2022) Obesity and contraceptive use: impact on cardiovascular risk. ESC Heart Fail 9:3761\u20133767. https:\/\/doi.org\/10.1002\/ehf2.14104","journal-title":"ESC Heart Fail"},{"key":"3050_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3803\/EnM.2021.958","volume":"36","author":"SH Oguz","year":"2021","unstructured":"Oguz SH, Yildiz BO (2021) An Update on Contraception in Polycystic Ovary Syndrome. Endocrinol Metab (Seoul) 36:296\u2013311. https:\/\/doi.org\/10.3803\/EnM.2021.958","journal-title":"Endocrinol Metab (Seoul)"},{"key":"3050_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14:270\u2013284. https:\/\/doi.org\/10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"key":"3050_CR35","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/ejendo\/lvad082","volume":"189","author":"M Forslund","year":"2023","unstructured":"Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT et al (2023) Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Endocrinol 189:S1\u2013S16. https:\/\/doi.org\/10.1093\/ejendo\/lvad082","journal-title":"Eur J Endocrinol"},{"key":"3050_CR36","doi-asserted-by":"publisher","first-page":"769187","DOI":"10.3389\/fendo.2021.769187","volume":"12","author":"L Morimont","year":"2021","unstructured":"Morimont L, Haguet H, Dogn\u00e9 J-M, Gaspard U, Douxfils J (2021) Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk. Front Endocrinol (Lausanne) 12:769187. https:\/\/doi.org\/10.3389\/fendo.2021.769187","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3050_CR37","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1080\/14740338.2020.1839409","volume":"19","author":"M Luque-Ram\u00edrez","year":"2020","unstructured":"Luque-Ram\u00edrez M, Ortiz-Flores AE, Nattero-Ch\u00e1vez L, Escobar-Morreale HF (2020) A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy. Expert Opin Drug Saf 19:1559\u20131576. https:\/\/doi.org\/10.1080\/14740338.2020.1839409","journal-title":"Expert Opin Drug Saf"},{"key":"3050_CR38","doi-asserted-by":"publisher","first-page":"e817","DOI":"10.1210\/clinem\/dgad465","volume":"109","author":"J Melin","year":"2024","unstructured":"Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer PM et al (2024) Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab 109:e817\u2013836. https:\/\/doi.org\/10.1210\/clinem\/dgad465","journal-title":"J Clin Endocrinol Metab"},{"key":"3050_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40618-021-01691-5","volume":"45","author":"V Soldat-Stankovi\u0107","year":"2022","unstructured":"Soldat-Stankovi\u0107 V, Popovi\u0107-Peji\u010di\u0107 S, Stankovi\u0107 S, Prtina A, Male\u0161evi\u0107 G, Bjeki\u0107-Macut J et al (2022) The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. J Endocrinol Invest 45:583\u2013595. https:\/\/doi.org\/10.1007\/s40618-021-01691-5","journal-title":"J Endocrinol Invest"},{"key":"3050_CR40","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","volume":"109","author":"V Fitz","year":"2024","unstructured":"Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A et al (2024) Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab 109:1630\u20131655. https:\/\/doi.org\/10.1210\/clinem\/dgad762","journal-title":"J Clin Endocrinol Metab"},{"key":"3050_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","volume":"78","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Qiao J (2013) Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids 78:755\u2013760. https:\/\/doi.org\/10.1016\/j.steroids.2013.04.006","journal-title":"Steroids"},{"key":"3050_CR42","doi-asserted-by":"publisher","first-page":"107771","DOI":"10.1016\/j.pec.2023.107771","volume":"113","author":"B Presswala","year":"2023","unstructured":"Presswala B, De Souza LR (2023) The diagnostic experience of polycystic ovary syndrome: A scoping review of patient perspectives. Patient Educ Couns 113:107771. https:\/\/doi.org\/10.1016\/j.pec.2023.107771","journal-title":"Patient Educ Couns"},{"key":"3050_CR43","doi-asserted-by":"publisher","first-page":"103287","DOI":"10.1016\/j.eclinm.2025.103287","volume":"84","author":"HJ Teede","year":"2025","unstructured":"Teede HJ, Moran LJ, Morman R, Gibson M, Dokras A, Berry L et al (2025) Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey. eClinicalMedicine 84:103287. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103287","journal-title":"eClinicalMedicine"},{"key":"3050_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/cen.15038","volume":"100","author":"BH Al Wattar","year":"2024","unstructured":"Al Wattar BH, Teh JJ, Clarke S, Abbara A, Morman R, Wilcox A et al (2024) Healthcare and research priorities for women with polycystic ovary syndrome in the UK National Health Service: A modified Delphi method. Clin Endocrinol (Oxf) 100:459\u2013465. https:\/\/doi.org\/10.1111\/cen.15038","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3050_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s42000-020-00211-z","volume":"19","author":"S Livadas","year":"2020","unstructured":"Livadas S, Macut D, Bothou C, Kuliczkowska-P\u0142aksej J, Vryonidou A, Bjekic-Macut J et al (2020) Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort. Hormones (Athens) 19:531\u2013539. https:\/\/doi.org\/10.1007\/s42000-020-00211-z","journal-title":"Horm (Athens)"},{"key":"3050_CR46","doi-asserted-by":"publisher","first-page":"e250266","DOI":"10.1530\/EC-25-0266","volume":"14","author":"F Ramezani Tehrani","year":"2025","unstructured":"Ramezani Tehrani F, Fayaz M, Firouzi F, Azizi F, Tohidi M, Behboudi-Gandevani S (2025) Longitudinal trajectories of insulin resistance in women with polycystic ovary syndrome: a functional data analysis approach. Endocr Connect 14:e250266. https:\/\/doi.org\/10.1530\/EC-25-0266","journal-title":"Endocr Connect"},{"key":"3050_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12020-021-02801-2","volume":"74","author":"P Anagnostis","year":"2021","unstructured":"Anagnostis P, Paparodis RD, Bosdou JK, Bothou C, Macut D, Goulis DG et al (2021) Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies. Endocrine 74:245\u2013253. https:\/\/doi.org\/10.1007\/s12020-021-02801-2","journal-title":"Endocrine"},{"key":"3050_CR48","doi-asserted-by":"publisher","first-page":"110640","DOI":"10.1016\/j.diabres.2023.110640","volume":"199","author":"NYH Ng","year":"2023","unstructured":"Ng NYH, Wu H, Lau ESH, Zhang X, Yang A, Tsang AYT et al (2023) Young-onset diabetes in women with PCOS: a territory-wide retrospective analysis in Hong Kong. Diabetes Res Clin Pract 199:110640. https:\/\/doi.org\/10.1016\/j.diabres.2023.110640","journal-title":"Diabetes Res Clin Pract"},{"key":"3050_CR49","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/humupd\/dmad015","volume":"29","author":"M Mill\u00e1n-de-Meer","year":"2023","unstructured":"Mill\u00e1n-de-Meer M, Luque-Ram\u00edrez M, Nattero-Ch\u00e1vez L, Escobar-Morreale HF (2023) PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis. Hum Reprod Update 29:741\u2013772. https:\/\/doi.org\/10.1093\/humupd\/dmad015","journal-title":"Hum Reprod Update"},{"key":"3050_CR50","doi-asserted-by":"publisher","unstructured":"Immanuel J, Simmons D (2017) Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and meta-analysis. Curr Diab Rep 17:115. https:\/\/doi.org\/10.1007\/s11892-017-0943-7","DOI":"10.1007\/s11892-017-0943-7"},{"key":"3050_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11892-017-0943-7","volume":"17","author":"J Immanuel","year":"2017","unstructured":"Pandurevic S, Mancini I, Mitselman D, Magagnoli M, Teglia R, Fazzeri R et al (2023) Efficacy of very low-calorie ketogenic diet with the Pronokal\u00ae method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial. Endocr Connect 12:e220536. https:\/\/doi.org\/10.1007\/s11892-017-0943-7","journal-title":"Curr Diab Rep"},{"key":"3050_CR52","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1210\/jc.2013-2385","volume":"98","author":"JP Domecq","year":"2013","unstructured":"Domecq JP, Prutsky G, Mullan RJ, Hazem A, Sundaresh V, Elamin MB et al (2013) Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab 98:4655\u20134663. https:\/\/doi.org\/10.1210\/jc.2013-2385","journal-title":"J Clin Endocrinol Metab"},{"key":"3050_CR53","doi-asserted-by":"publisher","first-page":"808898","DOI":"10.3389\/fendo.2022.808898","volume":"13","author":"Y Gu","year":"2022","unstructured":"Gu Y, Zhou G, Zhou F, Wu Q, Ma C, Zhang Y et al (2022) Life Modifications and PCOS: old story but new tales. Front Endocrinol 13:808898. https:\/\/doi.org\/10.3389\/fendo.2022.808898","journal-title":"Front Endocrinol"},{"key":"3050_CR54","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12905-023-02732-2","volume":"23","author":"BC Sydora","year":"2023","unstructured":"Sydora BC, Wilke MS, McPherson M, Chambers S, Ghosh M, Vine DF (2023) Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care. BMC Womens Health 23:569. https:\/\/doi.org\/10.1186\/s12905-023-02732-2","journal-title":"BMC Womens Health"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03050-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:22:36Z","timestamp":1792578156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03050-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":54,"alternative-id":["3050"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-03050-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"30 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Generative AI was used for language editing, structural revision, and document formatting. The authors remain fully responsible for the scientific content, accuracy, interpretation, and final submitted text.","order":1,"name":"Ethics","label":"Generative AI disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors reported no financial conflicts of interest. Any relevant non-financial interests should be specified and confirmed by all authors before submission.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}